Skip to main content

Market Overview

Why Aptevo's Stock Is Trading Higher Today

Why Aptevo's Stock Is Trading Higher Today

Aptevo Therapeutics (NASDAQ: APVO) shares are trading higher on Tuesday after the company announced the first complete remission in a patient was observed in the ongoing APVO436 Phase 1 clinical trial.

Aptevo Therapeutics is a biosciences company. The company is engaged in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics. Its pipeline product includes Otlertuzumab, APVO414, Multiple ADAPTIR Candidates, ALG.APV-527, APVO436 and APVO210.

Aptevo Therapeutics shares were trading up 19.37% at $7.52 on Tuesday during the time of publication. The stock has a 52-week high of $11.73 and a 52-week low of $2.94.


Related Articles (APVO)

View Comments and Join the Discussion!

Posted-In: why it's movingNews

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at